Kidney Stone Management Market Size, Share & COVID-19 Impact Analysis, By Type (Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithonomy (PCNL) By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Regional Forecast, 2020-2027

The global kidney stone management market size was valued at USD 1.47 billion in 2019 and is projected to reach USD 2.21 billion by 2027, exhibiting a CAGR of 5.3% during the forecast period.

The market for kidney stone management devices is growing due to the rising preference for minimally invasive surgeries, minimum complications, less post-surgical pain, and less recurring rate of kidney stones. Moreover, increase in the prevalence of kidney stones is further driving the market. According to the Journal of the American Society of Nephrology 2018, kidney stone disease or nephrolithiasis, occurs worldwide, with a prevalence percentage of 7% in the adults, and more than 30% recurrence rate within 10 years. In addition, technological advancements in ureteroscopes such as fiber optics flexible ureteroscopes are likely to drive the market in the near future.

LATEST TRENDS

Innovations in Kidney Stone Treatment to Fuel the Market

The introduction of new techniques and devices in stone disease treatments are revolutionary for healthcare providers as well as for patients. Some of the new stone braking innovations includes miniaturized surgery, holmium laser technologies, and disposable ureteroscopes. In March 2020, Lumenis announced the clinical evidence and advantages in lithotripsy and benign prostatic hyperplasia (BPH) treatments using the MOSES Technology. This technology uses a highly energized laser to destroy kidney stones. MOSES is user friendly and helps doctors to rupture the stones without injuring surrounding tissues with minimum bleeding.

DRIVING FACTORS

Increase Prevalence of Kidney Stone Diseases to Accelerate Growth

The recurrence and prevalence of kidney stone diseases are increasing globally. There are limited options of adopting effective drugs to treat the disease. Urolithiasis is estimated to affect an estimated 12% of the world population at some point in their lifetime. According to a data published by the European Association of Urology and National Kidney Foundation 2019, in countries with high standard of life such as the U.S., Canada, and Sweden, the prevalence of this disease has been reported to be more than 10%. Moreover, some other diseases such as obesity, diabetes, and high blood pressure may increase the risk for kidney stones.

Growing Adoption of Minimally Invasive Stone Removal Procedures To Drive the Market Growth

Surgeons have rapidly adopted minimally invasive surgical (MIS) techniques for a wide range of applications.  High adoption of minimally invasive techniques in general surgery and its minimal side effects compared to open surgical procedures are likely to drive the demand for advanced procedures for kidney stone managements in near future. According to the journal of Advances in Chronic Kidney Diseases, minimally invasive treatments that have been adopted for mainly three stone diseases in the United States market include extracorporeal shock wave lithotripsy, ureteroscopic lithotripsy, and percutaneous nephrolithotomy. Surgeons are using minimally invasive surgical techniques to conduct procedures that were earlier performed as an open surgery. These changing market dynamics are propelling the demand for the kidney stone management devices.

RESTRAINING FACTORS

Side Effects Related with Shock Wave Lithotripsy to Hamper Growth

Despite the increasing incidence of stone diseases, there are certain factors that are limiting the adoption of its treatment. One of the major factors obstructing the growth of the market is its side effects such as bleeding around kidneys, blockage of urine due to broken stones, infections, and increase in the arterial blood pressure, among others. related to the shock wave lithotripsy. According to the American Journal of Kidney Diseases, shock wave lithotripsy may pose side effects such as rise in the arterial blood pressure, reduction in renal function, and stone recurrence. Together these complications are expected to hinder the market growth during the forecast period.

Impact of COVID– 19 on Kidney Stone Management Devices

The COVID-19 pandemic made an adverse impact on the kidney stone management sector, resulting in the drop in revenue. The lockdown caused by the pandemic resulted in the sluggish diagnosis rate forkidney stone disease. Many small hospitals and nursing homes were forced to temporarily shut their operations because of the Lockdown. This was done with an objective to break the transmission of infections and diversion of healthcare resources to manage COVID-19 patients. According to the Johns Hopkins University Carey Business School 2020, poor supply chain management, limited availability of raw materials, sluggish medical device manufacturing rate, and slowdown in economy are major factors hampering the kidney stone treatment devices market.

SEGMENTATION

By Type Analysis

Ureteroscopes Segment Held Dominating Share Owing to High Success Rates of Procedures

Based on type, the market is segmented into lithotripsy, ureteroscopy, and percutaneous Nephrolithonomy (PCNL). Among these, the ureteroscopy segment dominated the market in 2019. Minimally invasiveness of the ureteroscopes, high success rate and low recurrence rate are the major factors contributing to the dominance of this segment. Moreover, ureteroscopes is expected to record a significantly high CAGR due to the advantages offered by the segment.

By End User Analysis

Early Adoption of Innovative Technologies by Hospitals to Dominate Segment

Based on end-user, the market segments include hospitals, specialty clinics, and ambulatory surgical centers. Among them, the hospitals segment held the dominating kidney stone management market share. Growing number of patients with kidney stones and adoption of advanced technologies by hospitals are diving this segment. Moreover, satisfactory reimbursement provided by hospitals is the major factor responsible for growth of this segment. However, the specialty clinics segment is projected to register highest growth during the forecast period. Growing number of skilled surgeons, coupled with favorable reimbursement policies offered by the specialty clinics will augment the growth of the specialty clinics segment.

REGIONAL INSIGHTS

The market size for kidney stone management in North America stood at USD 555.7 million in 2019. This is characterized by higher prevalence and incidence of stone diseases, coupled with favorable reimbursement policies for health associated disorders. Moreover, the rising awareness among patient population about new treatment options for stone diseases and the availability of advanced medical devices in the region, are aiding to the expansion of the regional market. Europe, on the other hand, holds the second largest share due to the rising incidences of kidney stones. Factors such as higher acceptance of technologically advanced product in the region, rising healthcare expenditures, and favorable reimbursement policies are responsible for the share of the market. However, the market in Asia-Pacific is anticipated to record a reasonably higher CAGR during the forecast period. Growing patient awareness regarding advanced medical devices, and presence of a large patient pool and being the underpenetrated market are projected to drive the Asia Pacific urinary stone treatment devices market growth during the forecast period. The market in Latin America and the Middle East & Africa are currently in a promising stage. However, the developing healthcare infrastructure in these regions and growing prevalence of stone diseases will boost this market demand during the forecast period.

KEY INDUSTRY PLAYERS

Strong Focus on Partnerships and Acquisition to Strengthen Global Presence of Industry Leaders

The competitive landscape of the urolithiasis management devices market demonstrates the dominance of leading players operating such as Boston Scientific Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, and Richard Wolf GmbH. A diversified & technologically advanced product portfolio and global expansion of such products are prominent factors responsible for the dominance of these companies. Moreover, a strong emphasis on partnerships and acquisition strategies in the market is likely to help attract high market revenue in the forthcoming years.

LIST OF KEY COMPANIES PROFILED:

• Cook Medical Inc. (US)


• Boston Scientific Corporation (US)


• Olympus Corp. (Japan)


• C.R. Bard Inc. (BD) (US)


• STORZ MEDICAL AG (Switzerland)


• Richard Wolf GmbH (Germany)


• Lumenis (Israel)


• EDAP TMS (France)


• DirexGroup (Germany)


• Other prominent players

KEY INDUSTRY DEVELOPMENTS:

• September 2018 –Boston Scientific Corporation launched the LithoVue Empower Retrieval Deployment Device in the US and Europe for retrieval of kidney stones through flexible ureteroscopy (URS).


• October 2017–Lumenis launched the MOSES holmium technology for Urology applications in India. This geographical expansion of this product opened the new gateway of lucrative opportunities for the company

REPORT COVERAGE

The global kidney stone management market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, types, and end-users. Besides this, it offers insights into the market, current trends, and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.

Report Scope & Segmentation